Traders should monitor the completion of the Runway-SWK merger, which is a condition precedent to this amendment. The interest rate reduction is modest, but the extended interest-only period improves near-term cash flow. The unchanged maturity date suggests no significant change in the company's long-term debt profile.
Price Chart
Executive Summary
Eton Pharmaceuticals amended its credit agreement with SWK Funding LLC to extend the interest-only period to November 2026, reduce the interest rate from SOFR + 6.75% to SOFR + 6.55%, and lower the SOFR floor from 5.0% to 2.75%. The maturity date remains December 2027. This amendment is contingent on the completion of a merger involving Runway Growth Finance Corp. and SWK Holdings Corporation.
Key Financial Metrics
Key Facts
- Eton Pharmaceuticals amended its credit agreement with SWK Funding LLC on April 9, 2026
- The interest rate was reduced from SOFR + 6.75% to SOFR + 6.55%
- The SOFR floor was reduced from 5.0% to 2.75%
- The interest-only period was extended to November 2026
- The maturity date remains December 17, 2027
- The amendment is contingent on the completion of a merger between Runway Growth Finance Corp. and SWK Holdings Corporation
- No fees were paid to SWK for this amendment
Financial Impact
The interest rate reduction from SOFR + 6.75% to SOFR + 6.55% represents a 20 basis point decrease in borrowing costs. The extension of the interest-only period to November 2026 defers $3 million in principal payments.
Risk Factors
- The amendment is contingent on the Runway-SWK merger, which may not close
- The company still faces significant debt maturity in December 2027
- The modest interest rate reduction may not substantially improve financial flexibility
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-012381 |
| Document: eton20260409c_8k.htm | 0001437749-26-012381 |
| Document: 0001437749-26-012381-index-headers.html | 0001437749-26-012381 |
| Document: 0001437749-26-012381-index.html | 0001437749-26-012381 |
| Document: 0001437749-26-012381.txt | 0001437749-26-012381 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 8-K | $52.88 | awaiting T+60 | — | $50.18 (−5.11%) |
Oct 6, 2026 20d ago | 144 | $54.88 | awaiting T+60 | — | $50.18 (−8.56%) |
Sep 28, 2026 29d ago | 8-K | $59.18 | awaiting T+60 | — | $50.18 (−15.21%) |
Aug 31, 2026 8w ago | Insider Cluster | $60.43 | awaiting T+60 | — | $50.18 (−16.96%) |
Aug 28, 2026 8w ago | Insider Cluster | $60.44 | awaiting T+60 | — | $50.18 (−16.98%) |
Aug 24, 2026 9w ago | Insider Cluster | $63.05 | awaiting T+60 | — | $50.18 (+20.41%) |
Aug 19, 2026 9w ago | 144 | $61.48 | awaiting T+60 | — | $50.18 (+18.38%) |
Aug 5, 2026 11w ago | 8-K | $45.97 | awaiting T+60 | — | $50.18 (+9.16%) |
Aug 5, 2026 11w ago | Press Release | $45.97 | awaiting T+60 | — | $50.18 (+9.16%) |
Aug 4, 2026 12w ago | 8-K | $45.83 | awaiting T+60 | — | $50.18 (+9.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers